The experts at Saint Luke’s Cancer Institute provide early detection, expert diagnosis, personalized treatment options, and survivorship support to every patient. It’s what Saint Luke’s calls precision medicine: the right treatment for the right patient at the right time.

We offer one of the region’s only precision oncology programs for advanced cancers that’s staffed by clinical oncologists with expertise in genomic sequencing and computational biology. And Saint Luke's Hospital Koontz Center for Advanced Breast Cancer is the first facility in the U.S. dedicated exclusively to the comprehensive care of Stage 4 breast cancer.

Find an Oncologist


Multidisciplinary Teams

Cancer is complex, and the best outcomes happen when a diverse team of experts work together to develop a comprehensive treatment plan for each patient.

Learn more about our supportive oncology and rehabilitative services.


Research

Research is fundamental to what we do. Clinical trials help bring new therapies for patients.

With our clinical trial agreement with the internationally recognized WashU Medicine, we offer more than 200 National Cancer Institute-sponsored clinical trials and industry-led studies to our patients.

Cancers we treat

Cancer types
Specialty centers

Saint Luke's Hospital Center for Precision Oncology
5th Floor Peet Center, Entrance C
4401 Wornall Road
Kansas City, MO 64111 

Saint Luke's Hospital Koontz Center for Advanced Breast Cancer
3rd Floor Peet Center, Entrance C
4401 Wornall Road
Kansas City, MO 64111

Saint Luke's Frank and Evangeline Thompson Thoracic Center
4321 Washington St., Suite 6000
Kansas City, MO 64111

Location

Saint Luke's Cancer Institute
4401 Wornall Road 
Peet Center, Entrance C
Kansas City, MO 64111 
Phone: 816-932-3300

Events

We are proud to partner with Gilda's Club Kansas City to provide a variety or educational, therapeutic classes, and interactive workshops to our patients.

Saint Luke's News

May. 23, 2025

Health News You Can Use: Cancer Research Month

This week, Marc Roth, MD, medical director of gastrointestinal oncology at Saint Luke’s Cancer Institute and interim chief of medical oncology, is breaking down advancements in cancer research and what they mean for patients.
May. 16, 2025

Pushing Forward: How a Young Lawyer Rebounded from Stage 3 Colon Cancer

Weeks shy of the bar exam, the trajectory of Jackson’s life was rocked off course when he was diagnosed with stage 3 colon cancer. The 26-year-old’s diagnosis was an obstacle that he refused to let topple him.
Apr. 30, 2025

KSHB: ‘Have Hope’: Study Shows Immunotherapy Continues To Change Future of Cancer Treatment

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.